Purdue Pharma L.P. has awarded a grant to advance the National Community Pharmacists Association Foundationís efforts to stimulate community-pharmacy based research that helps improve patient care and education. Purdueís donation will support the NCPA Foundationís Catalyst Grant Award Program for Innovative Practice, with a focus on pain management.
Conducted over several years, this program will eventually generate a significant body of knowledge and evidence to highlight the effectiveness of pharmacy-provided services and the efficacy of pharmaceuticals when properly used. Each year, the selected best practices will be widely communicated to healthcare providers, policy makers, and patient and disease advocacy groups.
The Catalyst Grant Award Program will provide seed funding for the purpose of establishing or improving activities, methods, technologies, and processes related to the provision of community pharmacy-based patient care. The award will focus on a particular health condition for which a grant application and proposal must address to be eligible for consideration. Each grant will provide $3,000 or $5,000 to support up to an 8-month project.